This is supported by previous studies which show that the elevated level of OPN plasma level in patients with NSCLC are reduced after resection or following platinum-based chemotherapy, but seem to upturn with recurrence38,39. The gene discussed is SPP1; the disease is non-small cell lung carcinoma.